Dermatomyositis+1
RecruitingStudy on Anifrolumab for Adults with Polymyositis or Dermatomyositis
- Disease:DermatomyositisPolymyositis
- Substances:Anifrolumab
France- Participants:18–64 years · 65+ years
- Substances:Anifrolumab
- Sponsor:AstraZeneca AB
Rare diseases
Investigational molecules
Locations
Back to France417 clinical trials in Reims, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)
France
France
France
France
France
France
France
France
France
France
France
FranceThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research exploring treatments for various cancers, including multiple myeloma, colorectal cancer, and esophageal squamous cell carcinoma. Studies focus on evaluating novel therapies and combination treatments to improve patient outcomes.
Several trials investigate immunotherapy approaches and targeted treatments for specific genetic mutations.
Clinical trials examining innovative treatments for autoimmune disorders, with particular focus on rheumatoid arthritis and psoriatic conditions. Research aims to evaluate new therapeutic approaches and optimize existing treatments.
Studies emphasize long-term efficacy and safety profiles of various treatment regimens.
Advanced research in kidney transplantation focusing on preventing rejection and improving long-term outcomes. Studies evaluate new immunosuppressive strategies and monitoring protocols.
Trials aim to optimize post-transplant care and reduce rejection rates.
Tell us about your condition – we search every trial in Europe and connect you with the right site.